Crestchem Ltd
Incorporated in 1991, Crestchem Ltd is in
the field of processing, manufacturing, and trading and marketing, of specialty chemical
ingredients,[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees Count ・Standalone data |
|
||||||||||
| Customer Concentration (Top Customer Revenue Share) % ・Standalone data |
|||||||||||
| Concentration (Top 3 Customers Revenue Share) % ・Standalone data |
|||||||||||
| Research and Technology Expenses INR Thousands ・Standalone data |
|||||||||||
| Number of Reportable Business Segments Count ・Standalone data |
|||||||||||
| Core Product Forms (Caprylic/Capric Triglycerides) Count ・Standalone data |
|||||||||||
Documents
Announcements
-
Disclosure Under Regulation 30 (1) & 30 (2) Of SEBI ( SAST) Regulations,2011
3 Apr - Promoter group disclosed 9,01,049 shares, 30.03% holding, with no encumbrance as of 31 March 2026.
-
Board Meeting Outcome for Out Of Board Meeting Dated 31-03-2026
31 Mar - Reappointed Nirmit D. Patel as ED (01-04-2026 to 31-03-2031); remuneration subject to members' approval; hired Tansi Patel Rs30,000/month.
-
Closure of Trading Window
26 Mar - Trading window closed Apr 1, 2026 until 48 hours after audited Q4/year FY2026 results announcement.
-
Board Meeting Intimation for General Discussion For The Performance During The Year 2025-26 & To Discuss The Plan For The Performance For The Coming Year 2026-27.
Nitin S.Shah
25 Mar - Board meeting March 31, 2026 to review 2025-26 performance, approve MD/ED remuneration, and issue duplicate share certificates.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
16 Feb - Extract of unaudited results for quarter/nine months ended Dec 31, 2025 published Feb 15, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2][3]
CL specializes in manufacturing, processing, marketing, and exporting nutraceutical ingredients used in health food, personal care, and specialty chemicals. Its key products, Caprylic/Capric Triglycerides in oil and powder form, along with downstream derivatives, also have industrial applications.